or Try an Advanced Search...

    Technical Analysis for DTIL - Precision BioSciences, Inc.

    Grade Last Price % Change Price Change
    F 9.02 5.37% 0.46
    DTIL closed up 5.37 percent on Friday, November 1, 2024, on 1.17 times normal volume.
    Earnings due: Nov 4
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Up
    Historical DTIL trend table...
    Date Alert Name Type % Chg
    Slingshot Bearish Bearish Swing Setup 0.00%
    Crossed Above 20 DMA Bullish 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Gapped Up Strength 0.00%
    Slingshot Bearish Bearish Swing Setup 5.37%
    Bullish Engulfing Bullish 5.37%
    Stochastic Buy Signal Bullish 5.37%
    Pocket Pivot Bullish Swing Setup 5.37%
    Volume Surge Other 5.37%
    New 52 Week Low Weakness 5.37%
    Older End-of-Day Signals for DTIL ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakout about 23 hours ago
    1.5x Volume Pace about 23 hours ago
    Up 5% about 23 hours ago
    Up 3% about 23 hours ago
    Up 1 ATR about 23 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    DTIL Chart by TradingView
    Basic chart:

    Profile

    Precision BioSciences is dedicated to improving life (DTIL) through its proprietary genome editing platform, “ARCUS.” Precision leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and create healthy and sustainable food and agriculture solutions. Precision is actively developing product candidates in three innovative areas: allogeneic CAR T immunotherapy, in vivo gene correction, and food.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Immunotherapy Cancer Treatment Virotherapy Human Diseases Genome Genome Editing

    Is DTIL a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 1 Precision BioSciences Q3 2024 Earnings Preview
    Nov 1 Precision BioSciences (DTIL) Surges 6.1%: Is This an Indication of Further Gains?
    Oct 29 Precision BioSciences to Report Third Quarter Results on November 4, 2024
    Oct 28 Precision BioSciences to Host Virtual Investor Event Highlighting PBGENE-HBV Preclinical Safety Data and Phase 1 Clinical Trial Plans on November 15, 2024
    Oct 24 Precision BioSciences Presents Preclinical Data Highlighting the Capability of ARCUS for High-Efficiency Gene Editing Utilizing Homology-Directed Repair at the ESGCT 31st Annual Congress
    Oct 24 Precision BioSciences to Report Q3 Earnings: What's in the Cards?
    Oct 24 Precision BioSciences Receives First Approval of Clinical Trial Application to Initiate PBGENE-HBV First-In-Human Study for the Treatment of Chronic Hepatitis B
    Oct 21 Precision BioSciences to Participate in Upcoming Longwood Boston CEO and Guggenheim Healthcare Conferences
    Oct 16 Precision BioSciences to Present at the European Society of Gene & Cell Therapy (ESGCT) 31st Annual Congress
    Oct 4 Cartesian Therapeutics, Inc. (RNAC) Moves 26.9% Higher: Will This Strength Last?
    See more DTIL news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 19.4299
    52 Week Low 7.97
    Average Volume 66,110
    200-Day Moving Average 10.86
    50-Day Moving Average 9.37
    20-Day Moving Average 8.75
    10-Day Moving Average 8.51
    Average True Range 0.42
    RSI (14) 53.70
    ADX 18.36
    +DI 21.99
    -DI 17.21
    Chandelier Exit (Long, 3 ATRs) 8.54
    Chandelier Exit (Short, 3 ATRs) 9.24
    Upper Bollinger Bands 9.40
    Lower Bollinger Band 8.10
    Percent B (%b) 0.71
    BandWidth 14.90
    MACD Line -0.23
    MACD Signal Line -0.26
    MACD Histogram 0.0259
    Fundamentals Value
    Market Cap 1.1 Billion
    Num Shares 122 Million
    EPS -0.86
    Price-to-Earnings (P/E) Ratio -10.49
    Price-to-Sales 0.94
    Price-to-Book 1.60
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 9.83
    Resistance 3 (R3) 9.78 9.46 9.70
    Resistance 2 (R2) 9.46 9.25 9.49 9.65
    Resistance 1 (R1) 9.24 9.13 9.35 9.29 9.60
    Pivot Point 8.92 8.92 8.98 8.95 8.92
    Support 1 (S1) 8.70 8.71 8.81 8.75 8.44
    Support 2 (S2) 8.38 8.59 8.41 8.39
    Support 3 (S3) 8.16 8.38 8.35
    Support 4 (S4) 8.21